Visualization of the impact of group, choroidal thickness (CT) and central choroidal thickness (cCT) on the visibility of large choroidal vessels (LCV). by Valentin Hacker (9956024)

Table 1_Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target.docx by Lili Zhou (265076)

“…However, the specific role and underlying molecular mechanisms of cholesterol metabolism alterations in diffuse large B-cell lymphoma (DLBCL) remain poorly understood.…”

Data_Sheet_1_The Proximal Drivers of Large Fires: A Pyrogeographic Study.docx by Hamish Clarke (8666307)

“…As in most fire-prone environments, the majority of annual burned area is due to a relatively small number of large fires. We train and test an Artificial Neural Network’s ability to predict spatial patterns in the probability of large fires (>1,250 ha) in forests and grasslands as a function of proxies of the four major controls on fire activity. …”

Data Sheet 1_Cholesterol metabolic reprogramming drives the onset of DLBCL and represents a promising therapeutic target.docx by Lili Zhou (265076)

“…However, the specific role and underlying molecular mechanisms of cholesterol metabolism alterations in diffuse large B-cell lymphoma (DLBCL) remain poorly understood.…”

DataSheet1_Adverse childhood experiences, brain function, and psychiatric diagnoses in a large adult clinical cohort.pdf by David B. Keator (19842939)

“…However, no study has explored these associations in a large clinical population to identify brain regions that may mediate the relationship between ACEs and psychiatric diagnoses. …”

Method for the Large-Scale Synthesis of Multifunctional 1,4-Dihydro-pyrrolo[3,2‑<i>b</i>]pyrroles by Mariusz Tasior (1457731)

Method for the Large-Scale Synthesis of Multifunctional 1,4-Dihydro-pyrrolo[3,2‑<i>b</i>]pyrroles by Mariusz Tasior (1457731)

Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx by Dewan Zhao (21547445)

“…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …”

Seven out of the 11 human cytidine deaminases are more highly expressed in tumor versus normal tissue and their higher expression is correlated with a decrease in survival. by Mason A. McCool (11889842)

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

The HMR complex components BOH1 and BOH2 largely colocalize with HMR in proximity to centromeres and HP1a domains (related to Fig 1). by Andrea Lukacs (3752956)

Autaptic neurotransmission accounts for a large fraction of the total inhibition onto single PV cells. by Charlotte Deleuze (501971)

Radiation can decrease the expression of the SCFAs in colon contents. by Liying Zhang (102453)

FARs’ role in increased mortality and microbe load is not limited to the LD₃₀ dose. by Sophia C. Parks (11624976)

“…A&C) Survival was measured daily showing that FARs significantly increase mortality rate in most doses. …”

Supplementary Material for: Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease by Fabbrocini G. (7463126)

“…<b><i>Objective:</i></b> To evaluate how the burden of HS disease impacts on patient well-being and working activities in a large Italian population over a period of 9 months. …”

Image_1_Comparison of first-line treatments for elderly patients with diffuse large B-cell lymphoma: A systematic review and network meta-analysis.tif by Yangyang Wang (642852)

Table_1_Comparison of first-line treatments for elderly patients with diffuse large B-cell lymphoma: A systematic review and network meta-analysis.docx by Yangyang Wang (642852)

A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas by L. E. van der Meeren (7490675)

“…<div><p>Diffuse large B-cell lymphoma—not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgroup of non-Hodgkin lymphoma. …”

Table_2_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf by Tianqi Xu (9574329)

“…Background<p>Anaplastic diffuse large B-cell lymphoma(A-DLBCL) is a rare morphological subtype characterized by the presence of polygonal, bizarre-shaped tumor cells. …”

Table_1_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf by Tianqi Xu (9574329)

“…Background<p>Anaplastic diffuse large B-cell lymphoma(A-DLBCL) is a rare morphological subtype characterized by the presence of polygonal, bizarre-shaped tumor cells. …”